Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3373 |  ACIU AC Immune SA - Common Stock | 2.55 USD | -0.78% | -10.21% | -6.59% | -27.14% | 259.44 M USD | ||
| 3383 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.13 USD | -0.93% | -8.97% | -11.98% | +32.30% | 255.22 M USD | ||
| 3387 |  STRO Sutro Biopharma, Inc. - Common Stock | 15.32 USD | +4.50% | -5.14% | -14.94% | -11.90% | 254.02 M USD | ||
| 3391 |  PALI Palisade Bio, Inc. - Common Stock | 1.45 USD | -2.03% | -0.68% | -29.27% | -14.71% | 252.69 M USD | ||
| 3420 |  IMRX Immuneering Corporation - Class A Common Stock | 3.74 USD | -3.11% | -8.78% | -17.44% | -40.35% | 241.97 M USD | ||
| 3450 |  EVMN Evommune, Inc. Common Stock | 6.40 USD | +2.89% | -10.86% | -39.05% | -63.05% | 232.27 M USD | ||
| 3454 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 1.82 USD | -7.14% | +8.98% | +62.50% | +100.00% | 231.60 M USD | ||
| 3459 |  KROS Keros Therapeutics, Inc. - common stock | 11.64 USD | +3.84% | +2.28% | +4.30% | -22.91% | 230.79 M USD | ||
| 3470 |  MGNX MacroGenics, Inc. - Common Stock | 3.55 USD | 0.00% | -2.47% | -12.99% | +100.56% | 226.14 M USD | ||
| 3471 |  ALEC Alector, Inc. - Common Stock | 2.02 USD | +5.21% | +5.76% | -9.01% | -36.08% | 225.55 M USD | ||
| 3481 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 15.14 USD | -1.62% | -14.22% | +4.13% | +33.86% | 222.23 M USD | ||
| 3484 |  SION Sionna Therapeutics, Inc. - Common Stock | 4.90 USD | +1.66% | -5.59% | -33.78% | -87.54% | 221.54 M USD | ||
| 3492 |  PLX Protalix BioTherapeutics, Inc. Common Stock | 2.70 USD | -0.37% | -0.37% | +2.27% | -7.53% | 217.54 M USD | ||
| 3499 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 8.79 USD | +2.69% | -7.96% | -30.79% | -63.66% | 215.40 M USD | ||
| 3500 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 5.53 USD | -1.43% | +0.73% | -21.00% | -20.66% | 215.32 M USD | ||
| 3513 |  NAGE Niagen Bioscience, Inc. - Common Stock | 2.66 USD | -2.21% | -2.21% | -12.21% | -46.59% | 210.48 M USD | ||
| 3530 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 6.82 USD | +2.10% | -6.83% | -20.05% | -25.55% | 206.34 M USD | ||
| 3531 |  IVVD Invivyd, Inc. - Common Stock | 0.70 USD | -4.11% | -15.66% | -10.26% | -65.00% | 206.33 M USD | ||
| 3540 |  ADCT ADC Therapeutics SA Common Shares | 1.59 USD | +11.97% | +44.55% | +29.27% | -65.05% | 202.99 M USD | ||
| 3547 |  CGEN Compugen Ltd. - Ordinary Shares | 2.12 USD | -1.40% | -9.40% | -14.52% | +8.72% | 200.45 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |